Project Grant R44HD118898
Award Date 9/15/25
Completion Date 8/31/27
Dollars Obligated $1.1M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
- This Project Grant award of $380,692 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865), is for the development of an ultrapotent anti-sperm antibody construct for a non-hormonal contraceptive. The project aims to create a novel intravaginal ring product that releases an anti-sperm antibody to agglutinate and trap sperm, thereby preventing pregnancy. The award supports the...
- This $474,946 Project Grant awarded on February 1, 2025 by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a novel, multipurpose device for female-initiated, non-hormonal contraception. The key products to be delivered under this grant include: Design and prototyping of a dual-compartment vaginal device that enables women to administer a bioresponsive polymer fiber mat...
- The National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865), awarded a $518,754 project grant to Magee-Womens Research Institute and Foundation. The goal of this project is to develop a bioadhesive vaginal film that can provide sustained release of contraceptive and antiviral monoclonal antibodies for 3-7 days. The film is intended to offer women a discreet, low-cost, and convenient...
- The U.S. National Institute of Child Health and Human Development (NICHD) awarded a $399,999 Project Grant to Sacyl Pharmaceuticals, Inc. under the Child Health and Human Development Extramural Research program (CFDA 93.865) to advance the development of a novel on-demand, non-hormonal male contraceptive towards Investigational New Drug (IND) enablement. The project aims to develop small molecule inhibitors of soluble adenylyl cyclase (ADCY10; SAC) in sperm, which has been genetically and...
- This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD), is funding a Phase 1 clinical trial to evaluate the safety and pharmacokinetics of a novel contraceptive and microbicidal vaginal gel developed by Yaso Therapeutics Incorporated. The $545,966 award supports the first-in-human clinical assessment of the "YASO-GEL" product, which contains the active ingredient polyphenylene carboxymethylene sodium salt (PPCM). In addition to...
- The National Institute of Child Health and Human Development (NICHD) awarded a $383,114 Small Business Innovation Research (SBIR) Phase I project grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Venova Technologies Inc., a women-led and minority-led medical device startup company. The grant funds the development of a novel, non-hormonal, long-acting female contraceptive device designed to address the critical unmet need for birth control options without hormonal...
- This federal Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to study the determinants of postpartum contraception and inter-pregnancy intervals. The total award amount is $1,371,278.00, with a project period from March 1, 2025 to November 30, 2029. The key objectives of this research project are to examine patient, partner, and provider factors that...
- This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate interventions for reducing barriers to contraceptive access in low-resource settings. The $110,901 grant, awarded on December 24, 2024, will support the University of North Carolina at Chapel Hill in conducting the following key activities: 1) estimating the...
- The University of Georgia Research Foundation, Inc. was awarded a $151,000 federal Project Grant under the National Institutes of Health's Child Health and Human Development Extramural Research program (CFDA 93.865). The research project, titled "Dysregulation of Uterine Fluid Movement as a Mechanism of Contraception," aims to investigate the role of uterine fluid dynamics in hormonal contraception and infertility. Key activities will include determining the time-course effects of...
- Hera Health Solutions Inc. received a $275,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program to develop a biodegradable contraceptive-releasing implant. The award aims to advance long-acting reversible contraception by creating an implant that delivers consistent hormone doses and does not require surgical removal. During the one-year period from May 1, 2023 to April 30, 2024, the company will characterize the drug delivery scaffold,...